InkTec Past Earnings Performance
Past criteria checks 5/6
InkTec has been growing earnings at an average annual rate of 57.3%, while the Chemicals industry saw earnings growing at 6.8% annually. Revenues have been growing at an average rate of 5.3% per year. InkTec's return on equity is 6.9%, and it has net margins of 7.5%.
Key information
57.3%
Earnings growth rate
58.0%
EPS growth rate
Chemicals Industry Growth | 13.9% |
Revenue growth rate | 5.3% |
Return on equity | 6.9% |
Net Margin | 7.5% |
Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Impressive Earnings May Not Tell The Whole Story For InkTec (KOSDAQ:049550)
Nov 26We Think That There Are More Issues For InkTec (KOSDAQ:049550) Than Just Sluggish Earnings
Mar 18Recent updates
Impressive Earnings May Not Tell The Whole Story For InkTec (KOSDAQ:049550)
Nov 26InkTec Co., Ltd.'s (KOSDAQ:049550) Share Price Could Signal Some Risk
May 10We Think That There Are More Issues For InkTec (KOSDAQ:049550) Than Just Sluggish Earnings
Mar 18Can You Imagine How InkTec's (KOSDAQ:049550) Shareholders Feel About The 37% Share Price Increase?
Mar 03InkTec (KOSDAQ:049550) Is Making Moderate Use Of Debt
Jan 09InkTec's (KOSDAQ:049550) Shareholders Are Down 49% On Their Shares
Nov 17Revenue & Expenses Breakdown
How InkTec makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Sep 24 | 71,429 | 5,323 | 8,819 | 3,238 |
30 Jun 24 | 69,015 | 5,892 | 7,991 | 3,043 |
31 Mar 24 | 65,965 | 4,343 | 8,018 | 2,991 |
31 Dec 23 | 62,809 | 3,712 | 7,772 | 2,980 |
30 Sep 23 | 61,022 | 2,254 | 8,182 | 3,075 |
30 Jun 23 | 60,076 | 2,282 | 8,464 | 3,128 |
31 Mar 23 | 60,237 | 3,237 | 8,623 | 3,130 |
31 Dec 22 | 61,537 | 3,963 | 8,654 | 3,063 |
30 Sep 22 | 62,281 | 5,101 | 8,496 | 2,921 |
30 Jun 22 | 61,424 | 5,731 | 8,017 | 2,770 |
31 Mar 22 | 57,484 | 5,498 | 7,182 | 2,536 |
31 Dec 21 | 55,168 | 1,675 | 6,715 | 2,533 |
30 Sep 21 | 52,617 | -917 | 6,720 | 2,597 |
30 Jun 21 | 50,182 | -1,319 | 5,445 | 2,767 |
31 Mar 21 | 47,766 | -2,686 | 6,103 | 3,002 |
31 Dec 20 | 48,320 | -544 | 7,131 | 3,229 |
30 Sep 20 | 49,925 | -2,740 | 10,872 | 3,465 |
30 Jun 20 | 53,205 | -3,448 | 13,235 | 3,643 |
31 Mar 20 | 58,647 | -3,067 | 13,606 | 3,807 |
31 Dec 19 | 59,078 | -2,834 | 13,499 | 3,937 |
30 Sep 19 | 57,274 | -1,805 | 10,570 | 4,044 |
30 Jun 19 | 55,322 | -3,396 | 10,677 | 4,168 |
31 Mar 19 | 53,683 | -4,224 | 11,124 | 4,339 |
31 Dec 18 | 55,347 | -4,250 | 11,368 | 4,386 |
30 Sep 18 | 55,599 | -7,103 | 12,404 | 4,186 |
30 Jun 18 | 56,033 | -4,698 | 12,919 | 4,560 |
31 Mar 18 | 57,716 | -6,012 | 13,733 | 4,859 |
31 Dec 17 | 57,608 | -8,870 | 14,000 | 5,328 |
30 Sep 17 | 61,941 | -3,398 | 13,627 | 5,084 |
30 Jun 17 | 66,887 | -6,326 | 13,411 | 4,568 |
31 Mar 17 | 71,544 | -3,967 | 13,512 | 4,238 |
31 Dec 16 | 73,536 | -2,298 | 13,859 | 3,568 |
30 Sep 16 | 75,108 | -16,185 | 13,744 | 3,789 |
30 Jun 16 | 74,879 | -16,952 | 14,292 | 3,979 |
31 Mar 16 | 74,960 | -19,278 | 14,570 | 4,135 |
31 Dec 15 | 77,217 | -19,527 | 14,881 | 4,404 |
30 Sep 15 | 79,543 | -13,189 | 16,613 | 5,021 |
30 Jun 15 | 81,009 | -14,298 | 16,596 | 5,446 |
31 Mar 15 | 84,127 | -13,384 | 16,419 | 5,881 |
31 Dec 14 | 85,648 | -12,307 | 16,025 | 5,909 |
30 Sep 14 | 85,218 | -6,160 | 14,558 | 5,654 |
30 Jun 14 | 86,773 | -3,600 | 14,388 | 5,375 |
31 Mar 14 | 89,465 | -211 | 13,864 | 4,762 |
31 Dec 13 | 89,756 | 408 | 13,415 | 4,593 |
Quality Earnings: A049550 has high quality earnings.
Growing Profit Margin: A049550's current net profit margins (7.5%) are higher than last year (3.7%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: A049550 has become profitable over the past 5 years, growing earnings by 57.3% per year.
Accelerating Growth: A049550's earnings growth over the past year (136.1%) exceeds its 5-year average (57.3% per year).
Earnings vs Industry: A049550 earnings growth over the past year (136.1%) exceeded the Chemicals industry 21.4%.
Return on Equity
High ROE: A049550's Return on Equity (6.9%) is considered low.